Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Future Oncology (London, England)|August 20, 2019
Somatostatin analogs in association with peptide receptor radionucleotide therapy in advanced well-differentiated NETsNatalie Prinzi, Alessandra Raimondi, Marco Maccauro, et al.
Targeted Oncology|August 4, 2018
Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy ApproachesDaniela Femia, Natalie Prinzi, Andrea Anichini, et al.
World Journal of Gastrointestinal Oncology|September 4, 2020
One size does not fit all for pancreatic cancers: A review on rare histologies and therapeutic approachesMonica Niger, Michele Prisciandaro, Maria Antista, et al.
JAMA Network Open|January 8, 2024
NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer: A Systematic Review and Meta-AnalysisFederico Nichetti, Simone Rota, Paolo Ambrosini, et al.
Clinical Colorectal Cancer|April 7, 2019
Lack of Benefit From Anti-EGFR Treatment in RAS and BRAF Wild-type Metastatic Colorectal Cancer With Mucinous Histology or Mucinous ComponentRoberto Moretto, Federica Morano, Elena Ongaro, et al.
Cancers|January 21, 2022
Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable OutcomeDirk Andreas Ridder, Lana Louisa Urbansky, Hagen Roland Witzel, et al.
Cancer Research and Treatment|November 19, 2016
Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic Colorectal Cancer: A Literature-Based Systematic Review and Meta-AnalysisChiara Cremolini, Carlotta Antoniotti, Filippo Pietrantonio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2024
The Prostaglandin EP4 Antagonist Vorbipiprant Combined with PD-1 Blockade for Refractory Microsatellite-Stable Metastatic Colorectal Cancer: A Phase Ib/IIa TrialFilippo Pietrantonio, Federica Morano, Monica Niger, et al.
Cancers|November 13, 2020
Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast CancerMarianna Sirico, Ottavia Bernocchi, Navid Sobhani, et al.
ESMO Open|December 7, 2017
Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical studyChiara Cremolini, Filippo Pietrantonio, Gianluca Tomasello, et al.
Pageof 8